✦ LIBER ✦

Flumazenil may improve symptoms of Parkinson's disease

Book ID: 120859849
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200314000-00026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flumazenil, a GABA antagonist, may impro

Flumazenil, a GABA antagonist, may improve features of Parkinson's disease

✍ William G. Ondo; Christine Hunter 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

## Abstract Manipulation of γ‐aminobutyrate (GABA) system has been little studied in Parkinson's disease, despite the fact that GABA subserves a large part of the basal ganglia, including the outflow tracts. To test whether antagonism of GABA could improve features of PD, we administered open label

Flumazenil in Parkinson's disease

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Liatermin improves symptoms of Parkinson

Liatermin improves symptoms of Parkinson's disease

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Nicotine may relieve symptoms of Parkins

Nicotine may relieve symptoms of Parkinson's disease

✍ Karl Olov Fagerström; Ovide Pomerleau; Bruno Giordani; Fred Stelson 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 295 KB

Oxcarbazepine may induce psychotic sympt

Oxcarbazepine may induce psychotic symptoms in Parkinson’s disease

✍ Norbert Kovacs; Ferenc Nagy; Istvan Balas; Samuel Komoly; Jozsef Janszky 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Quetiapine improves psychotic symptoms a

Quetiapine improves psychotic symptoms and cognition in Parkinson's disease

✍ Jorge L. Juncos; Vicki J. Roberts; Marian L. Evatt; Rita D. Jewart; Colleen D. W 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract Twenty‐nine elderly patients who failed treatment with clozapine, risperidone, or olanzapine entered this 24‐week, single‐center, open‐label trial to assess the efficacy of quetiapine (12.5–400 mg/day) for psychosis in patients with Parkinson's disease (PD). Psychiatric, motor, and cogn